MetaboStem uses computational design to develop cancer treatments

MetaboStem uses computational design to develop cancer treatments

The biotechnology company MetaboStem, a spin-off of the Catalan Institute of Oncology (ICO), has signed an agreement with Mind the Byte to offer tailor-made computational services to develop antitumour drugs. The MetabosTem compounds specifically target cancer stem...